Takeda: Fistula trials
The registry lists 11 Fistula studies with Takeda as lead sponsor. 0 are open to participants now and 5 have results posted.
Phase 1 1Phase 2 2Phase 3 4No phase 5(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study of the Quality of Life in Adults With Crohn's Disease With Complex Perianal FistulasCompletedNCT04876690Results posted
- Long-term Follow-up Study With Darvadstrocel in the Treatment of Complex Perianal FistulaCompletedNCT04075825Phase 3Results posted
- Perianal Fistula (PAF) Validation and Burden of Illness StudyCompletedNCT03981939Results posted
- Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Participants With Crohn's Disease (CD)CompletedNCT03279081Phase 3Results posted
- An Efficacy and Safety Study of SRM003 in the Treatment of Subjects Undergoing Creation of an Arteriovenous Fistula to Facilitate Hemodialysis AccessCompletedNCT01806545Phase 2Results posted
- A Study of Surgical Interventions in Fistulizing ConditionsCompletedNCT04940611
- Health-Related Quality of Life in Crohn's Disease Participants With Complex Perianal Fistula Before and After TreatmentTerminatedNCT04102163
- Safety and Efficacy of Adipose-Derived Stem Cells to Treat Complex Perianal Fistulas Patients With Crohn's DiseaseTerminatedNCT01378390Phase 3
- Study to Assess the Safety and Efficacy of Expanded Allogenic Adipose-derived Stem Cells (eASCs) (Cx601), for Treatment of Complex Perianal Fistulas in Perianal Crohn's Disease.CompletedNCT01372969Phase 1/2
- Long-term Safety and Efficacy of Adipose-derived Stem Cells to Treat Complex Perianal Fistulas in Patients Participating in the FATT-1 Randomized Controlled TrialCompletedNCT01020825
- Efficacy and Safety of Adipose Stem Cells to Treat Complex Perianal Fistulas Not Associated to Crohn´s DiseaseCompletedNCT00475410Phase 3